Myrtelle Announces Presentation of Positive 12-month Post Treatment Data in its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy at the 2023 Cell & Gene Meeting on the Mesa held by the Alliance for Regenerative Medicine
Wakefield, Mass., October 10, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Article Date
October 10, 2023
This article is featured on another website.
Go to article
February 26, 2026
Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026
February 26, 2026
Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026
May 12, 2026
HiRO Is Attending DIA China 2026: Meet Us in Shanghai
Visit HiRO at Booth TF01 to discuss Modern, Disciplined CRO Solutions HiRO is excited to…
May 12, 2026
HiRO Is Attending DIA China 2026: Meet Us in Shanghai
Visit HiRO at Booth TF01 to discuss Modern, Disciplined CRO Solutions HiRO is excited to…